Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
COVID-19
56%
Orchestra
26%
Gut Microbiota
22%
Bloodstream Infection
20%
Oncology Patients
20%
Extended-spectrum beta-lactamase-producing Enterobacteriaceae
20%
Post-acute Infection Syndromes
20%
Decolonization
20%
Post-COVID-19 Condition
20%
Latent Transition Analysis
20%
RNA Shedding
20%
Prospective Cohort Study
20%
Early Predictors
20%
Non-hospitalized
20%
Low-grade Inflammation
20%
Coronavirus Disease (COVID)
20%
SARS-CoV-2 Infection
15%
Post-acute
13%
Infectious Diseases
13%
Chemotherapy
12%
Clinical Data
10%
Selective Digestive Decontamination
10%
Disease Severity
10%
Patient Management
9%
Acute Infection
9%
Throat Swab
8%
Householder
8%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
8%
Blood Samples
8%
Nasopharyngeal
8%
Disease Onset
7%
Gut Microbiota Composition
7%
Time-resolved
6%
Covariate Information
6%
Initial Infection
6%
Clinical Trials
6%
Patient Characteristics
6%
Complex Time
6%
Patient Monitoring
6%
Multimodal Data
6%
European Centers
6%
Disease Phenotype
6%
Therapeutic Development
6%
Disease Trajectory
6%
Patient Assessment
6%
Clinical Case Definition
6%
Patient-level Analysis
6%
Patient Journey
6%
Hospitalization
6%
Biochemical Parameters
5%
Immunology and Microbiology
COVID-19
100%
Infection
40%
Infectious Disease
33%
Severe Acute Respiratory Syndrome Coronavirus 2
30%
Enterobacterales
20%
Ribonucleic Acid
20%
Intestine Flora
20%
Inflammation
20%
Feces
8%
Prevalence
8%
Medicine and Dentistry
Infection
32%
Post-COVID-19
30%
COVID-19
20%
Quality of Life
20%
Bloodstream Infection
20%
Extended Spectrum Beta Lactamase
20%
Cluster Analysis
20%
Inflammation
20%
Longitudinal Study
20%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Chemotherapy
13%
Diseases
11%
Prevalence
8%
Principal Component Analysis
6%
Patient Monitoring
5%
Patient Assessment
5%
Case Definition
5%
Patient Management
5%
Patient Characteristics
5%
Clinical Research
5%
